Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia
- PMID: 39235624
- PMCID: PMC11446942
- DOI: 10.1007/s00134-024-07613-2
Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia
Abstract
Purpose: The aim of this study was to evaluate one-year outcomes of lower versus higher oxygenation targets in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.
Methods: We conducted pre-planned analyses of one-year mortality and health-related quality of life (HRQoL) in the Handling Oxygenation Targets in COVID-19 trial. The trial randomised 726 ICU patients with COVID-19 and hypoxaemia to partial pressure of arterial oxygen targets of 8 kPa (60 mmHg) versus 12 kPa (90 mmHg) during ICU stay up to 90 days, including readmissions. HRQoL was assessed using EuroQol visual analogue scale (EQ-VAS) and 5-level 5-dimension questionnaire (EQ-5D-5L). Outcomes were analysed in the intention-to-treat population. Non-survivors were assigned the worst possible score (zero), and multiple imputation was applied for missing EQ-VAS values.
Results: We obtained one-year vital status for 691/726 (95.2%) of patients and HRQoL data for 642/726 (88.4%). At one year, 117/348 (33.6%) of patients in the lower-oxygenation group had died compared to 134/343 (39.1%) in the higher-oxygenation group (adjusted risk ratio: 0.85; 98.6% confidence interval (CI) 0.66-1.09; p = 0.11). Median EQ-VAS was 50 (interquartile range, 0-80) versus 40 (0-75) (adjusted mean difference: 4.8; 98.6% CI - 2.2 to 11.9; p = 0.09) and EQ-5D-5L index values were 0.61 (0-0.81) in the lower-oxygenation group versus 0.43 (0-0.79) (p = 0.20) in the higher-oxygenation group, respectively.
Conclusion: Among adult ICU patients with COVID-19 and severe hypoxaemia, one-year mortality results were most compatible with benefit of the lower oxygenation target, which did not appear to result in more survivors with poor quality of life.
Keywords: COVID-19; Intensive care units; Mortality; Oxygen inhalation therapy; Quality of life.
© 2024. The Author(s).
Conflict of interest statement
The Department of Intensive Care at Rigshospitalet (AP, MNK) received funding from Sygeforsikringen “Danmark”, The Novo Nordisk Foundation, the Ehrenreich Foundation, the Becketts Foundation, and AM-Pharma. TL has served in Data and Safety Monitoring Board for Novo Nordisk and Leo Pharma, respectively: the studies were unrelated to the present study.
Figures



Similar articles
-
Long-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia.Intensive Care Med. 2022 Jun;48(6):714-722. doi: 10.1007/s00134-022-06695-0. Epub 2022 Apr 20. Intensive Care Med. 2022. PMID: 35441849 Free PMC article. Clinical Trial.
-
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.Intensive Care Med. 2022 May;48(5):580-589. doi: 10.1007/s00134-022-06677-2. Epub 2022 Mar 31. Intensive Care Med. 2022. PMID: 35359168 Free PMC article. Clinical Trial.
-
Lower or higher oxygenation targets in the intensive care unit: an individual patient data meta-analysis.Intensive Care Med. 2024 Aug;50(8):1275-1286. doi: 10.1007/s00134-024-07523-3. Epub 2024 Jul 11. Intensive Care Med. 2024. PMID: 38990335 Free PMC article.
-
Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit.Cochrane Database Syst Rev. 2019 Nov 27;2019(11):CD012631. doi: 10.1002/14651858.CD012631.pub2. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Sep 13;9:CD012631. doi: 10.1002/14651858.CD012631.pub3. PMID: 31773728 Free PMC article. Updated.
-
Effects of Oxygenation Targets on Mortality in Critically Ill Patients in Intensive Care Units: A Systematic Review and Meta-Analysis.Anesth Analg. 2024 Oct 1;139(4):734-742. doi: 10.1213/ANE.0000000000006859. Epub 2024 Sep 4. Anesth Analg. 2024. PMID: 38315626
Cited by
-
In-depth analysis of the risk factors for persistent severe acute respiratory syndrome coronavirus 2 infection and construction of predictive models: an exploratory research study.BMC Infect Dis. 2025 May 14;25(1):699. doi: 10.1186/s12879-025-11083-2. BMC Infect Dis. 2025. PMID: 40369416 Free PMC article.
-
Less is best for oxygen therapy in adults in the intensive care unit with severe hypoxaemia due to COVID-19.Intensive Care Med. 2024 Oct;50(10):1685-1687. doi: 10.1007/s00134-024-07554-w. Epub 2024 Sep 12. Intensive Care Med. 2024. PMID: 39264414 No abstract available.
References
-
- Alhazzani W, Evans L, Alshamsi F, Moller MH, Ostermann M, Prescott HC et al (2021) Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med 49(3):e219–e234. 10.1097/CCM.0000000000004899 - PubMed
-
- Schjørring OL, Klitgaard TL, Perner A, Wetterslev J, Lange T, Siegemund M et al (2021) Lower or higher oxygenation targets for acute hypoxemic respiratory failure. N Engl J Med 384(14):1301–1311. 10.1056/NEJMoa2032510 - PubMed
-
- van der Wal LI, Grim CCA, Del Prado MR, van Westerloo DJ, Boerma EC, Rijnhart-de Jong HC et al (2023) Conservative versus liberal oxygenation targets in intensive care unit patients (ICONIC): a randomized clinical trial. Am J Respir Crit Care Med 208(7):770–779. 10.1164/rccm.202303-0560OC - PMC - PubMed
-
- Klitgaard TL, Schjørring OL, Nielsen FM, Meyhoff CS, Perner A, Wetterslev J et al (2023) Higher versus lower fractions of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit. Cochrane Database Syst Rev 9(9):Cd012631. 10.1002/14651858.CD012631.pub3 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical